The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwNHL 2019 | The need for academic and pharmaceutical collaboration in drug development
From the 17th International Workshop on Non-Hodgkin Lymphoma held in Boston, MA, John Gribben, MD, of Barts Cancer Institute, London, UK, and Jay Bradner, MD, President of Novartis Institutes for BioMedical Research, Cambridge, MA, discuss the need for academic and pharmaceutical collaboration to advance treatments for patients. Dr Bradner also describes the process of research and development at Novartis, emphasizing its similarities with academia.
